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Backgrounds/Aims: With development of imaging techniques, pancreatic tumors are being diagnosed more frequently. 
Applying the standard surgical procedures for pancreatic head tumors, such as pancreaticoduodenectomy and pylo-
rus-preserving pancreaticoduodenectomy may seem too extensive for benign or low-grade malignant pancreas head 
tumors. Duodenum-preserving pancreatic head resection (DPPHR) has been safely performed in patients with chronic 
pancreatitis. Recently, DPPHR has been used as a limited surgical procedure to remove benign or low-grade malignant 
pancreatic head lesions. This study is aimed to evaluate the results of DPPHR in benign or low-grade malignant tumors. 
Methods: Between 2004 and 2012, six patients underwent DPPHR due to benign or low-grade malignant pancreas 
tumor. We performed this retrospective analysis based on the medical records. Results: Five of six patients were diag-
nosed as intraductal papillary mucinous neoplasms. Remaining one patient was diagnosed as solid pseudopapillary 
neoplasm. The median age of patients was 60.3 (27-75) years, and the median follow-up period was 24 months. The 
operation time, blood loss and length of stay were 442.5 minutes, 680 ml and 19.2 days, respectively. There was 
no mortality. Five patients experienced complications including 1 delayed gastric empting, 2 bile duct strictures, 1 pan-
creatic fistula and 1 duodenal stricture. No recurrence or metastasis was found during follow-up. Conclusions: In benign 
and low-grade malignant lesions of pancreatic head, DPPHR could be alternative to traditional surgery. For applying 
DPPHR in pancreas tumor, a thorough preoperative examination and utilization of frozen section for sufficient resection 
margin are required. (Korean J Hepatobiliary Pancreat Surg 2013;17:126-130)
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INTRODUCTION
Subclinical pancreas cystic tumors are being found 
more frequently recently, owing to the development and 
widespread use of new imaging techniques.1 Pancreas 
cystic tumor consists of serous cysteadenoma, mucinous 
cystic neoplasm, intraductal papillary mucinous neoplasm 
and solid pseudopapillary neoplasm. Each tumor shows 
distinct biological features and malignant potential. 
However, it is difficult to distinguish the benign from ma-
lignant lesions preoperatively. It is a challenge to decide 
on a surgical treatment due to morbidity and mortality fol-
lowing the surgery.2,3 
In particular, pancreaticoduodenectomy and pylorus- 
preserving pancreaticoduodenectomy have been tradition-
ally performed on pancreatic head lesions. With the devel-
opment of surgical techniques, the operations have shown 
low complication and mortality rates as compared to the 
past. However, it is inevitable that the pancreas and near-
by organs lose some of their functions. To this end, vari-
ous organ-preserving pancreatic resections have been re-
searched to resolve the issues. The representative method 
for pancreatic head lesions is duodenum-preserving pan-
creatic head resection (DPPHR). DPPHR in pancreatic tu-
mor was first introduced by Beger for chronic pancreatitis 
patients.4 The application has expanded to chronic pan-
creatitis, precancerous lesions and pancreatic head tumors 
with low malignance.5
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Table 1. Characteristics of patients
Patient Gender/age Preoperative symptom Diagnosis 
A
B
C
D
E
F
Male/72
Female/27
Male/75
Female/64
Male/62
Male/61
Back pain
None
None
None
None
None
IPMN
SPN
IPMN
IPMN
IPMN
IPMN
IPMN, intraductal papillary mucinous neoplasm; SPN, solid 
pseudopapillary neoplasm
Table 2. Surgical outcomes of duodenum-preserving pancreas 
head resection 
Patient
Operation 
time 
(minutes)
Blood 
loss 
(ml)
Length 
of stay Complication 
A
B
C
D
E
F
313
369
485
420
N/A
625
200
500
1,300
500
N/A
900
22
11
25
28
17
12
Delayed gastric 
emptying
Pancreatic 
pseudocyst
Gastric outlet 
obstruction
None 
Biliary stricture 
(PTBD)
Biliary stricture 
(ERCP - Stent)
PTBD, percutaneous transhepatic biliary drainage; ERCP, en-
doscopic retrograde cholangiopancreatography; N/A, not 
available
We performed this study to investigate the efficacies of 
duodenum-preserving pancreatic head resection for cystic 
neoplasm of the pancreatic head by analyzing post-
operative outcomes.
METHODS
The number of patients who underwent DPPHR in pan-
creatic tumor at Yonsei University Severance Hospital 
(Seoul, Korea) between October 2004 and March 2012 
was eight. Among them, six patients underwent operation 
due to benign or low malignant pancreatic tumor. The ret-
rospective analysis was based on the medical records. 
RESULTS
The total number of patients who received DPPHR in 
pancreatic head tumor was six. The average age of pa-
tients was 60.3 (27-75) years old, and there were 4 male 
and 2 female patients. One patient was symptomatic and 
the remaining five patients were discovered incidentally 
by imaging studies (Table 1).
The average operation time, blood loss and length of 
stay were 442.5 minutes, 680 ml and 19.2 days, respec-
tively. Combined organ resection was performed for one 
patient. The patient underwent DPPHR with right radical 
nephrectomy due to renal cell carcinoma (Table 2).
The histopathologic examination showed that 5 of 6 
cases were the intraductal papillary mucinous neoplasms 
and the remaining one case was solid pseudopapillary 
neoplasm. No lymph node metastases were found among 
intraductal papillary mucinous neoplasms from the histo-
pathologic examinations. Solid pseudopapillary neoplasm 
showed less than 5% of cytologic atypia and atypical mi-
tosis, and β-catenin was positive to nuclear pattern from 
the immunohistochemical examination (Fig. 1). 
There was no mortality, and five patients showed com-
plications including 1 delayed gastric stricture. The de-
layed gastric empting was improved by conservative 
treatment. A pancreatic fistula was found in one patient 
post-operation due to solid pseudopapillary neoplasm- 
formed cyst and was treated by cysto-pancreatic dou-
ble-sided pigtail insert by the endoscopic approach. Bile 
duct strictures were found in 2 patients: percutaneous 
transhepatic biliary drainage (PTBD) was performed for 
one patient; and endoscopic retrograde biliary drainage 
was performed for the other patient. One patient suffered 
from repetitive duodenal ulcer due to ischemia. He experi-
enced frequent vomiting from duodenal stricture caused 
by ulcer. To relieve obstructive symptoms, we conducted 
endoscopic balloon dilatation, only to be unsuccessful. 
Finally, we performed gastrojejunostomy (Fig. 2).
No recurrence of pancreatic lesions was found on the 
clinical shadow tracking. Average observation period was 
24 months.
DISCUSSION
The advantage of DPPHR compared to traditional pan-
creaticoduodenectomy and pylorus-preserving pancreati-
coduodenectomy is the preservation of duodenum, which 
has a key role in the digestive and absorptive functions. 
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Fig. 1. A case of solid pseudopapillary neoplasm. (A) A 10 cm-sized, septated, cystic mass in the pancreas head. (B) Duodenum,
distal common bile duct and posterior inferior pancreaticoduodenal artery (PDA) were preserved during the duodenum-preserving
pancreatic head resection. (C) Atypical mitosis; Tripolar mitosis (arrow) (H-E, ×400). (D) β-catenin was found to be positive 
for nuclear pattern (×400). 
In addition, preservation of more pancreatic tissues and 
normal biliary tree makes it possible to improve the pa-
tient’s quality of life.6,7 The most significant reason for 
duodenum resection with pancreas head is the danger of 
duodenal ischemia. 
Duodenum receives arterial blood from the pan-
creaticoduodenal artery, which originates from the gastro-
duodenal artery and superior mesenteric artery. It forms 
an arcade, contacting duodenum at the front and pancreas 
head at the rear. Beger preserved thin pancreatic layers 
with arcade blood vessels near the internal duodenum to 
preserve duodenum and they resected pancreas head of 
chronic pancreatitis patients. Beger’s technique has been 
modified in various forms, including a complete resection 
of pancreas head and preservation of duodenal blood 
vessels. It has been reported that a resection of pancreas 
head, bile duct inside the pancreas and the arcade have 
been performed while maintaining the blood supply from 
a small artery on the abdominal walls of the duodenum.8 
Takada et al.9,10 designed a technique by completely re-
secting the pancreas head and preserving posterior arcade 
Miyakawa et al.11 published a technique which preserved 
the anterior arcade.
We performed gastrojejunostomy for one patient due to 
repetitive ulcer and stricture from duodenal ischemia. 
Extra caution needs to be taken with duodenal stricture, 
because DPPHR in pancreatic tumor completely resects 
pancreatic tissues inside the duodenum to secure the 
boundary surface from the center for pancreatic cystic 
disease. Multi-detector computed tomography may be 
considered to check the bloodstream around duodenum 
before the surgery.12
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Fig. 2. Complications presenting
duodenal stricture. (A) Ischemic 
change at the duodenal 2nd por-
tion (arrow). (B) Huge ulcero-in-
filtrative lesion at duodenum. 
(C) Duodenal stricture. (D) Pne-
umatic balloon dilatation of the 
duodenum.
Table 3. Indications for duodenum-preserving total pancreatic head resection for cystic neoplastic tumors
Indications for duodenum-preserving total pancreatic head resection
Clinical symptomatic cystic tumors
Clinical asymptomatic cystic tumors
Histological criteria
IPMN
MCN
SCA
SPN
Endocrine tumor
IPMN
MCN
SCA
SPN
Adenoma
Borderline lesion
Carcinoma in situ
Localized in pancreatic head
Absence of signs for malignancy
Absence of signs for multifocality
Main- and branch-duct tumor
Compression of CBD or PDM, size ＞2 cm
Growing, compression of CBD or PMD
Surgery for all
Size ＞2 cm
Adhesion/infiltration to duodenum
Main duct type
Branch duct type, size ＞2 cm or presence of mural nodes
Surgery for all monocentric lesions
Cysts ＞3 cm 
Surgery for all
IPMN, intraductal papillary mucinous neoplasm; MCN, mucinous cystic neoplasm; SCA, serous cystadenoma; SPN, solid pseudo-
papillary neoplasm; CBD, common bile duct; PMD, pancreas main duct
Issues including duodenal ischemia, proper operation 
indication and securing oncologic radicality are other con-
cerns when applying DPPHR to pancreatic head tumor.
Frequent pancreatic cystic tumors include intraductal 
papillary mucinous neoplasm, mucinous cystic neoplasm, 
serous cystadenoma, and solid pseudopapillary neoplasm. 
Indication for DPPHR is a tumor placed on the pancreas 
head with clinical symptoms. The operative indications 
shall be judged as depending on the size and features of 
each lesion and connection with the pancreatic duct, if 
there are no clinical symptoms. There needs also be no 
evidence of malignancy or multifocality (Table 3).13,14 
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Table 4. Indications for oncologic pancreatic head resection (pancreaticoduodenectomy, pylorus-preserving pancreaticoduodenec-
tomy) of cystic neoplastic tumors
Indications for oncologic pancreatic head resection
Cystic neoplasia, preoperatively suspected 
to be associated with invasive carcinoma
Intraoperative criteria
Jaundice
Malignant cells in juice
Mural nodes ＞0.5 cm
New onset diabetes
CEA ＞110 mg/ml in cystic fluid
Duct dilatation ＞1 cm
Cancer cell positive lymph nodes
Adhesion to portal vein, superior mesenteric vein
Infiltration into proximal duodenum or wall of gastric antrum
Frozen section: suspected cancer cells behind subepithelial level of the duct
Cancer cell positive resection margin
Clinical aspects suspicious malignance include jaundice, 
new diabetes, pancreatic duct expansion (＞1 cm), in-
creasing carcinoembryonic antigen (CEA) in cystic fluids 
and existence of mural node. Clinical opinions with strong 
suspicion of malignance shall be considered for pan-
creaticoduodenectomy or pylorus-preserving pancreatico-
duodenectomy (Table 4).13 
Lastly, oncologic radicality is important in applying 
DPPHR in precancerous lesions and malignant cystic 
diseases. Frozen section examination shall be applied in 
the operation room to secure the sufficient resection mar-
gin to prevent recurrence of the precancerous lesion and 
existence of malignant lesion. Additional resection is re-
quired on the resection margin if borderline atypia, pan-
creatic intraepithelial neoplasm (PanIN 3) is found.13 
In conclusion, DPPHR in pancreas head tumor with 
precancerous lesions and low malignance may be replaced 
with a typical operation. It is required to secure a suffi-
cient resection margin by utilizing the frozen section ex-
amination and checking for indications thorough pre-
operative examination. The operation must be performed 
by experienced surgeons due to the possibility of damag-
ing the bile duct and causing duodenal ischemia. 
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